Canadian Agency for Drugs and Technologies in Health. (2019). Axicabtagene ciloleucel for large B-cell lymphoma Health technology assessment introduction and clinical review protocol. Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Axicabtagene Ciloleucel for Large B-cell Lymphoma Health Technology Assessment Introduction and Clinical Review Protocol. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2019.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Axicabtagene Ciloleucel for Large B-cell Lymphoma Health Technology Assessment Introduction and Clinical Review Protocol. Canadian Agency for Drugs and Technologies in Health, 2019.
